Sheehy, Susanne H <br/><br/>
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.  [electronic resource] 

 -  PloS one  2012 
 - e31208 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0031208  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviruses, Simian--genetics<br/>Adolescent<br/>Adult<br/>Animals<br/>Antibodies, Neutralizing--immunology<br/>Antibodies, Protozoan--immunology<br/>Antigens, Protozoan--immunology<br/>Enzyme-Linked Immunospot Assay<br/>Female<br/>Genetic Vectors--genetics<br/>Humans<br/>Immunization<br/>Interferon-gamma--immunology<br/>Life Cycle Stages<br/>Malaria Vaccines--adverse effects<br/>Malaria, Falciparum--immunology<br/>Male<br/>Middle Aged<br/>Plasmodium falciparum--growth & development<br/>T-Lymphocytes--immunology<br/>Vaccinia virus--genetics<br/>Young Adult